Neuphoria Therapeutics Inc.
NEUP · XNASCIK 1191070fmd_07B7H2VST1969HTDV6WEBR0MGWManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jul 01, 2019 to Jun 30, 2026, 16 periods
Latest annual · FY2026
Millions- Total revenues
- 1
- Operating income
- (16)
- Net income
- (13)
Latest quarter · Q4 FY2026
Millions- Operating income
- (6)
- Net income
- (5)
Daily close · NEUPIEX trades only
Sep 19, 2025 to Nov 11, 2026 · 250 sessions2.70 USD
Built from trades executed at IEX only, one exchange with a small share of US volume. This is not the consolidated tape. The close is the last IEX trade of the session, not the official closing price. Earlier sessions are divided by the later split ratios the API confirmed against IEX prices; dividends are not adjusted. Switch to As traded for the prices as they printed. End of day, not real time: a session is published the day after it trades.
Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. iex.io/legal/hist-data-terms
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2023 to FY2026
- n/m
Neuphoria Therapeutics Inc. (NEUP) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2026 | FY2025 | Change | Source |
|---|---|---|---|---|
| Revenue | $1.2 million | $15.6 million | -92.5% | 10-K 2026-09-18 · proof |
| Operating income | -$16.5 million | -$1.1 million | 10-K 2026-09-18 · proof | |
| Net income | -$13.5 million | -$369,632 | 10-K 2026-09-18 · proof | |
| Cash from operating activities | -$12.4 million | $77,229 | -16,095.4% | 10-K 2026-09-18 · proof |
| Total assets | $28.7 million | $28.6 million | +0.4% | 10-K 2026-09-18 · proof |
| Total liabilities | $4.1 million | $9.6 million | -57.1% | 10-K 2026-09-18 · proof |
| Cash and cash equivalents | $19.9 million | $14.2 million | +39.8% | 10-K 2026-09-18 · proof |
- What was Neuphoria Therapeutics Inc. (NEUP)'s revenue in fiscal 2026?
- Neuphoria Therapeutics Inc. (NEUP) reported revenue of $1.2 million for fiscal 2026 (the year ended Jun 30, 2026), against $15.6 million the year before (-92.5%). Source: the 10-K filed with the SEC on Sep 18, 2026. SEC
- What was Neuphoria Therapeutics Inc. (NEUP)'s operating income in fiscal 2026?
- Neuphoria Therapeutics Inc. (NEUP) reported operating income of -$16.5 million for fiscal 2026 (the year ended Jun 30, 2026), against -$1.1 million the year before. Source: the 10-K filed with the SEC on Sep 18, 2026. SEC
- What was Neuphoria Therapeutics Inc. (NEUP)'s net income in fiscal 2026?
- Neuphoria Therapeutics Inc. (NEUP) reported net income of -$13.5 million for fiscal 2026 (the year ended Jun 30, 2026), against -$369,632 the year before. Source: the 10-K filed with the SEC on Sep 18, 2026. SEC
- What was Neuphoria Therapeutics Inc. (NEUP)'s cash from operating activities in fiscal 2026?
- Neuphoria Therapeutics Inc. (NEUP) reported cash from operating activities of -$12.4 million for fiscal 2026 (the year ended Jun 30, 2026), against $77,229 the year before (-16,095.4%). Source: the 10-K filed with the SEC on Sep 18, 2026. SEC
- What are Neuphoria Therapeutics Inc. (NEUP)'s total assets?
- As of Jun 30, 2026, Neuphoria Therapeutics Inc. (NEUP) reported total assets of $28.7 million, against $28.6 million a year earlier (+0.4%). Source: the 10-K filed with the SEC on Sep 18, 2026. SEC
- What are Neuphoria Therapeutics Inc. (NEUP)'s total liabilities?
- As of Jun 30, 2026, Neuphoria Therapeutics Inc. (NEUP) reported total liabilities of $4.1 million, against $9.6 million a year earlier (-57.1%). Source: the 10-K filed with the SEC on Sep 18, 2026. SEC
- What are Neuphoria Therapeutics Inc. (NEUP)'s cash and cash equivalents?
- As of Jun 30, 2026, Neuphoria Therapeutics Inc. (NEUP) reported cash and cash equivalents of $19.9 million, against $14.2 million a year earlier (+39.8%). Source: the 10-K filed with the SEC on Sep 18, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:NEUP&period_type=annual&limit=5"Information only, not investment advice.